Kistler Tiffany Companies LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,566 shares of the healthcare conglomerate’s stock after buying an additional 176 shares during the period. Kistler Tiffany Companies LLC’s holdings in UnitedHealth Group were worth $585,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Intellectus Partners LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth about $111,000. Thomas J. Herzfeld Advisors Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth about $111,000. Cribstone Capital Management LLC increased its stake in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the period. Israel Discount Bank of New York GFN acquired a new stake in UnitedHealth Group during the fourth quarter worth about $139,000. Finally, Massmutual Trust Co. FSB ADV acquired a new stake in UnitedHealth Group during the fourth quarter worth about $140,000. Institutional investors and hedge funds own 86.67% of the company’s stock.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 185.95 on Wednesday. The firm has a 50-day moving average price of $178.98 and a 200-day moving average price of $168.66. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $188.66. The company has a market capitalization of $179.19 billion, a PE ratio of 23.80 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The business had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a return on equity of 21.42% and a net margin of 4.13%. UnitedHealth Group’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.80 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were paid a $0.75 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.63. The ex-dividend date was Thursday, June 15th. This represents a $3.00 annualized dividend and a yield of 1.61%. UnitedHealth Group’s payout ratio is currently 37.36%.
ILLEGAL ACTIVITY NOTICE: This piece was reported by BBNS and is the sole property of of BBNS. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://baseballnewssource.com/markets/unitedhealth-group-incorporated-nyseunh-stake-raised-by-kistler-tiffany-companies-llc/1180085.html.
A number of analysts recently issued reports on UNH shares. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Deutsche Bank AG started coverage on shares of UnitedHealth Group in a research report on Wednesday, April 5th. They set a “buy” rating and a $183.00 target price for the company. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 target price for the company in a research report on Wednesday, April 5th. Cantor Fitzgerald reissued an “overweight” rating and set a $200.00 target price on shares of UnitedHealth Group in a research report on Thursday, April 6th. Finally, Mizuho increased their target price on shares of UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, April 18th. One investment analyst has rated the stock with a hold rating, twenty-three have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $185.76.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 838 shares of the business’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $169.12, for a total value of $141,722.56. Following the transaction, the director now owns 28,528 shares of the company’s stock, valued at $4,824,655.36. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP D Ellen Wilson sold 14,000 shares of the business’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total value of $2,387,560.00. Following the completion of the transaction, the executive vice president now directly owns 31,993 shares in the company, valued at approximately $5,456,086.22. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,378 shares of company stock worth $5,285,052. 0.89% of the stock is owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with our FREE daily email newsletter.